TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07140562: Prospective, Multi-Center, Single-Arm Study: Safety and Technical Feasibility of the Tangent Tricuspid Annular Therapy System for Transcatheter Valve Repair in Patients With Severe, Symptomatic Functional Tricuspid Regur

Sponsor: Tangent Cardiovascular Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 25 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$4,714,400

Rescue Site Savings

+$3,120,800

Unlock Full NCT07140562 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07140562 Rescue Dossier →